Related Experiment Video
Updated: Aug 14, 2026
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Heart disease in diabetic patients
1University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8856, USA. Robert.toto@utsouthwestern.edu
Insights
Diabetics with chronic kidney disease face high risks of heart problems. Managing blood pressure, cholesterol, and using specific medications significantly reduces cardiovascular events in type 2 diabetes.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Diabetes significantly increases cardiovascular morbidity and mortality, especially in patients with chronic kidney disease (CKD).
- Diabetics exhibit higher prevalence of hypertension and dyslipidemia, leading to a two-to-four-fold increased risk of coronary artery disease.
- Chronic kidney disease further elevates the incidence of cardiovascular complications by nearly two-fold.
Purpose of the Study:
- To review the complex pathophysiology of cardiac disease in diabetes, including microvascular and macrovascular aspects.
- To highlight the cardioprotective effects of renin-angiotensin system inhibitors in diabetic patients with early kidney disease.
- To summarize evidence-based interventions for reducing cardiovascular risk in type 2 diabetes.
Main Methods:
- Review of recent studies and cardiovascular outcomes trials.
- Analysis of multifactorial risk intervention strategies.
- Discussion of novel therapeutic approaches for diabetics with nephropathy.
Main Results:
- Treatment with renin-angiotensin system blockers shows cardioprotective benefits in diabetics with microalbuminuria and early CKD.
- Comprehensive risk factor management (BP control, lipid lowering, glycemic control, ACE inhibitors/ARBs, aspirin, smoking cessation) reduces cardiovascular events in type 2 diabetes.
- Ongoing trials investigate the impact of anemia treatment and optimal dyslipidemia control on outcomes in diabetics with nephropathy.
Conclusions:
- Aggressive management of multiple cardiovascular risk factors is crucial for preventing cardiac disease in type 2 diabetics.
- Further research, including novel therapeutic strategies, is needed to improve quality of life and prevent cardiac disease in diabetic patients, particularly those with CKD.
Abstract:
Cardiac artery disease and heart failure are major causes for morbidity and mortality in diabetes in general and in those with chronic kidney disease (CKD) in particular. Hypertension and dyslipidemia are more common in diabetes and the prevalence of coronary artery disease in diabetics is two-fold to four-fold higher than in nondiabetics. In those with CKD the incidence of cardiovascular complications is nearly two-fold higher than those without CKD. Recent studies suggest that the pathophysiology of cardiac disease is complex process involving both microvascular and macrovascular disease. In addition, myocardial lipotoxicity may be a novel contributing factor particularly in type 2 diabetics. Compelling evidence from cardiovascular outcomes trials indicates that treatment with drugs that block the renin-angiotensin system are cardioprotective in diabetics with microalbuminuria and early stages of kidney disease. Multiple risk factor intervention aimed at optimal blood pressure control (BP <130/<80 mmHG), lowering LDL cholesterol below 100 mg/dl, lowering triglyceride level to 150 mg/dl, A1C <6.5%, treatment with an ACE inhibitor or an angiotensin II receptor blocker, administration of once daily low-dose aspirin and smoking cessation together reduce cardiovascular morbidity and mortality in type 2 diabetics. Novel studies including diabetics with nephropathy aimed at improving outcomes in diabetics by treatment of anemia and optimal control of dyslipidemia are now underway. These and other clinical trials should provide important new insights into improving the quality of life in diabetics and ultimately preventing cardiac disease.
Related Concept Videos
01:27Diabetic Retinopathy
01:22Diabetic Neuropathy
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:22Complications of Diabetes Mellitus
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:28Diabetic Nephropathy